Prophase labs inc

Major-Pharmaceuticals

PRPH


621 North Shady Retreat Road
Doylestown , PA 18901

Executive/
Director

Price

  • Last Close
  • $ 2.42
    $ +0.02 0.63 %
    Aug 29, 2024
  • 52-Week High/Low
  • $7.39 - $2.07
  • YTD
  • -46.6%

  • Trading Volume
  • 1,220
  • Market Cap Full
  • $ 43.7M
  • Shares Outstanding
  • 18M
    Nov 6, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -10.2% -7.2% 13.5% 36.3% 3.1% -5% -19.4% -2.4% -20.9% 43.1%
Q2 -5% -5.8% -8.3% 36.8% -30.5% 4% -16.2% 81.1% -4.7% 0.6%
Q3 26.9% 49.5% 2.6% -4.8% -20.2% 8% -16.1% -11% -39.8% -
Q4 -5.1% 2.1% 1.3% 6.2% 10% 165.3% 37.9% -14.6% 3.2% -
J F M A M J J A S O N D
2024 7.3% -7.8% 44.7% 6.5% - - - - - - - -
2023 -15.1% -10.6% 4.2% -1.6% 26.5% -23.5% 0.3% -41.2% 2.1% 0.5% 15.5% -10.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -9%3%33%8%83%-32%364%-22%34%-53%-47%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.09 0.08 0.95 - -0.09 -0.07 0.06 0.68 0.03
Q2 0.10 0.06 0.09 -0.02 -0.11 0.01 -0.09 0.4 -0.20
Q3 0.04 0.01 0.05 -0.09 -0.04 -0.04 -0.26 0.06 -0.30
Q4 0.07 0.04 - -0.04 -0.03 -0.08 0.69 -0.12 -
A 0.3 0.2 1.1 -0.2 -0.3 -0.2 0.4 1 -0.47

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2019 2021
Q1 0.25 0.3
Q2 0.25 -
Q3 - -
Q4 - -
A 0.5 0.3
2018 2019 2020 2021 2022 2023
Mar - 11.6 11.6 15.2 15.5 17.2
Jun 11.1 11.6 11.6 15.2 15.5 17.2
Sep 11.5 11.6 11.6 15.2 16 16.8
Dec 11.5 11.6 11.6 15.5 16.3 18

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 13 7.4 3.3 7 4
Fixed Asset Turnover 15.4 11.3 2.5 5 4.3
Total Asset Turnover 1.4 0.9 0.5 0.8 0.6
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 4 2.5 - - -
Equity multiplier 0.1 0.1 0.6 0.2 0.2